LB001/#1731 Late-breaking abstract presentation: overall survival by number of prior lines of chemotherapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer receiving olaparib treatment or non-platinum chemotherapy in SOLO3
Charles Leath Iii, G. Scambia, R. Villalobos, N. Colombo, D. Cibula, M. Bidziński, Jae-Weon Kim, J. Nam, R. Mądry, C. Hernández, P. Mora, S. Ryu, M. Ah-See, E. Lowe, N. Lukashchuk, Dave Carter, R. Penson
{"title":"LB001/#1731 Late-breaking abstract presentation: overall survival by number of prior lines of chemotherapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer receiving olaparib treatment or non-platinum chemotherapy in SOLO3","authors":"Charles Leath Iii, G. Scambia, R. Villalobos, N. Colombo, D. Cibula, M. Bidziński, Jae-Weon Kim, J. Nam, R. Mądry, C. Hernández, P. Mora, S. Ryu, M. Ah-See, E. Lowe, N. Lukashchuk, Dave Carter, R. Penson","doi":"10.1136/ijgc-2022-igcs.1","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":348678,"journal":{"name":"Oral Abstracts (Regular and Late-Breaking Submission)","volume":"2022 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Abstracts (Regular and Late-Breaking Submission)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-igcs.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
